A new study finds that under 30% of radiology-focused AI/ML devices authorized by the FDA had clinical testing prior to authorization.
Key Details
- 1FDA has cleared over 1,000 AI/ML devices, most for radiology.
- 2Research published in JAMA Network Open reviewed almost 1,000 algorithms approved from 1995 to June 2024.
- 3Of 723 radiology devices, fewer than 30% underwent any form of clinical testing.
- 4Very few devices were subject to prospective trials before clearance.
- 5Authors highlight a lack of standards for safety and efficacy in FDA authorization of AI/ML devices.
Why It Matters
The rapid proliferation of AI/ML devices in radiology without adequate clinical validation raises concerns about patient safety and efficacy. The findings emphasize an urgent need for more rigorous regulatory oversight and defined testing standards for imaging AI tools.
Source
Radiology Business
Related News
•AuntMinnie
AI Enables Safe 75% Gadolinium Reduction in Breast MRI Without Losing Sensitivity
AI-enhanced breast MRI with a 75% reduced gadolinium dose maintained diagnostic sensitivity comparable to full-dose protocols.
•Radiology Business
NVIDIA Envisions Autonomous AI Agents Transforming Radiology
NVIDIA foresees a major shift in radiology toward autonomous AI agents and imaging systems that could revolutionize patient care.
•Cardiovascular Business
Deep Learning AI Model Detects Coronary Microvascular Dysfunction Via ECG
A new AI algorithm rapidly detects coronary microvascular dysfunction using ECGs, with validation incorporating PET imaging.